{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:39:27Z","timestamp":1768433967490,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Foundation of National Nature Science in China","award":["No.81372809"],"award-info":[{"award-number":["No.81372809"]}]},{"name":"National Clinical Research Center for Gynecological Oncology","award":["No.2015BAI13B05"],"award-info":[{"award-number":["No.2015BAI13B05"]}]},{"name":"the Department of Medical and Health Science Technology of Shandong Province","award":["No.2016WS0345"],"award-info":[{"award-number":["No.2016WS0345"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-5218-4","type":"journal-article","created":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T02:20:15Z","timestamp":1546050015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1\/c-Abl apoptosis signaling pathway"],"prefix":"10.1186","volume":"18","author":[{"given":"Yue","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4946-2033","authenticated-orcid":false,"given":"Xingsheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,29]]},"reference":[{"issue":"5","key":"5218_CR1","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1053\/j.gastro.2009.07.039","volume":"137","author":"E Stoffel","year":"2009","unstructured":"Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S, Gruber SB. Calculation of risk of colorectal and endometrial cancer among patients with lynch syndrome. Gastroenterology. 2009;137(5):1621\u20137.","journal-title":"Gastroenterology"},{"issue":"3","key":"5218_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrm2858","volume":"11","author":"S Negrini","year":"2010","unstructured":"Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability\u2014an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11(3):220\u20138.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5218_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"issue":"21","key":"5218_CR4","first-page":"4881","volume":"56","author":"D Fink","year":"1996","unstructured":"Fink D, Nebel S, Aebi S, Zheng H, Cenni B, Nehm\u00e9 A, Christen RD, Howell SB. The role of DNA mismatch repair in platinum drug resistance. Cancer Res. 1996;56(21):4881\u20136.","journal-title":"Cancer Res"},{"issue":"1","key":"5218_CR5","first-page":"1","volume":"4","author":"D Fink","year":"1998","unstructured":"Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance. Clin Cancer Res. 1998;4(1):1\u20136.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"5218_CR6","first-page":"2758","volume":"62","author":"F Mayer","year":"2002","unstructured":"Mayer F, Gillis AJ, Dinjens W, Oosterhuis JW, Bokemeyer C, Looijenga LH. Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment. Cancer Res. 2002;62(10):2758\u201360.","journal-title":"Cancer Res"},{"issue":"8","key":"5218_CR7","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/ijc.23291","volume":"122","author":"A Velasco","year":"2008","unstructured":"Velasco A, Corvalan A, Wistuba II, Riquelme E, Chuaqui R, Majerson A, Leach FS. Mismatch repair expression in testicular cancer predicts recurrence and survival. Int J Cancer. 2008;122(8):1774\u20137.","journal-title":"Int J Cancer"},{"issue":"16","key":"5218_CR8","doi-asserted-by":"publisher","first-page":"14564","DOI":"10.1074\/jbc.M111.225375","volume":"286","author":"A Kothandapani","year":"2011","unstructured":"Kothandapani A, Dangeti VS, Brown AR, Banze LA, Wang XH, Sobol RW, Patrick SM. Novel role of base excision repair in mediating cisplatin cytotoxicity. J Biol Chem. 2011;286(16):14564\u201374.","journal-title":"J Biol Chem"},{"issue":"15","key":"5218_CR9","doi-asserted-by":"publisher","first-page":"7332","DOI":"10.1093\/nar\/gkt479","volume":"41","author":"A Kothandapani","year":"2013","unstructured":"Kothandapani A, Sawant A, Dangeti VS, Sobol RW, Patrick SM. Epistatic role of base excision repair and mismatch repair pathways in mediating cisplatin cytotoxicity. Nucleic Acids Res. 2013;41(15):7332\u201343.","journal-title":"Nucleic Acids Res"},{"key":"5218_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.dnarep.2015.10.003","volume":"35","author":"A Sawant","year":"2015","unstructured":"Sawant A, Kothandapani A, Zhitkovich A, Sobol RW, Patrick SM. Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links. DNA Repair (Amst). 2015;35:126\u201336.","journal-title":"DNA Repair (Amst)"},{"issue":"6","key":"5218_CR11","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101\u20138.","journal-title":"Nat Protoc"},{"issue":"1","key":"5218_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1478-811X-11-6","volume":"11","author":"C Meyer","year":"2013","unstructured":"Meyer C, Dzieran J, Liu Y, Schindler F, Munker S, M\u00fcller A, Coulouarn C, Dooley S. Distinct dedifferentiation processes affect caveolin-1 expression in hepatocytes. Cell Commun Signal. 2013;11(1):6.","journal-title":"Cell Commun Signal"},{"issue":"32","key":"5218_CR13","first-page":"9","volume":"32","author":"NJ Kruger","year":"1994","unstructured":"Kruger NJ. The Bradford method for protein quantitation. In: methods in molecular biology. Clifton, NJ: Humana Press. 1994;32(32):9\u201315.","journal-title":"Clifton, NJ: Humana Press"},{"issue":"1","key":"5218_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4132\/jptm.2016.09.23","volume":"51","author":"W Li","year":"2016","unstructured":"Li W, Lee MR, Choi E, Cho MY. Clinicopathologic significance of Survivin expression in relation to CD133 expression in surgically resected stage II or III colorectal Cancer. J Pathol Transl Med. 2016;51(1):17\u201323.","journal-title":"J Pathol Transl Med"},{"issue":"10","key":"5218_CR15","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/cyto.a.20623","volume":"73","author":"JA Lee","year":"2008","unstructured":"Lee JA, Spidlen J, Boyce K, Cai J, Crosbie N, Dalphin M, et al. MIFlowCyt: the minimum information about a flow cytometry experiment. Cytometry A. 2008;73(10):926\u201330.","journal-title":"Cytometry A"},{"issue":"6","key":"5218_CR16","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.3892\/ol.2016.5365","volume":"12","author":"Z Liu","year":"2016","unstructured":"Liu Z, Yao L, Tan B, Li L, Chen B. Detection of microRNA-200b may predict the inhibitory effect of gefitinib on non-small cell lung cancer and its potential mechanism. Oncol Lett. 2016;12(6):5349\u201355.","journal-title":"Oncol Lett"},{"issue":"1","key":"5218_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bcp.2008.03.025","volume":"76","author":"PH Clingen","year":"2008","unstructured":"Clingen PH, Wu JY, Miller J, Mistry N, Chin F, Wynne P, Prise KM, Hartley JA. Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy. Biochem Pharmacol. 2008;76(1):19\u201327.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"5218_CR18","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1007\/s13277-015-4143-2","volume":"37","author":"J Jia","year":"2016","unstructured":"Jia J, Wang Z, Cai J, Zhang Y. PMS2 expression in epithelial ovarian cancer is posttranslationally regulated by Akt and essential for platinum-induced apoptosis. Tumor Biol. 2016;37(3):3059\u201369.","journal-title":"Tumor Biol"},{"issue":"16","key":"5218_CR19","first-page":"3579","volume":"58","author":"A Vaisman","year":"1998","unstructured":"Vaisman A, Varchenko M, Umar A, Kunkel TA, Risinger JI, Barrett JC, et al. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. Cancer Res. 1998;58(16):3579\u201385.","journal-title":"Cancer Res"},{"issue":"31","key":"5218_CR20","doi-asserted-by":"publisher","first-page":"21394","DOI":"10.1074\/jbc.M709954200","volume":"283","author":"LS Li","year":"2008","unstructured":"Li LS, Morales JC, Hwang A, Wagner MW, Boothman DA. DNA mismatch repair-dependent activation of c-Abl\/ p73alpha\/GADD45alpha-mediated apoptosis. J Biol Chem. 2008;283(31):21394\u2013403.","journal-title":"J Biol Chem"},{"issue":"24","key":"5218_CR21","doi-asserted-by":"publisher","first-page":"21801","DOI":"10.1074\/jbc.M111342200","volume":"277","author":"G Tomer","year":"2002","unstructured":"Tomer G, Buermeyer AB, Nguyen MM, Liskay RM. Contribution of human mlh1 and pms2 ATPase activities to DNA mismatch repair. J Biol Chem. 2002;277(24):21801\u20139.","journal-title":"J Biol Chem"},{"issue":"10","key":"5218_CR22","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1371\/journal.pgen.1003016","volume":"8","author":"SA Lujan","year":"2012","unstructured":"Lujan SA, Williams JS, Pursell ZF, Abdulovic-Cui AA, Clark AB, Nick McElhinny SA, Kunkel TA. Mismatch repair balances leading and lagging strand DNA replication fidelity. PLoS Genet. 2012;8(10):1003\u20136.","journal-title":"PLoS Genet"},{"issue":"5","key":"5218_CR23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","volume":"14","author":"LP Martin","year":"2008","unstructured":"Martin LP, Hamilton TC, Schilder RJ. Platinum resistance: the role of DNA repair pathways. Clin Cancer Res. 2008;14(5):1291\u20135.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"5218_CR24","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1158\/0008-5472.CAN-04-0513","volume":"64","author":"E Papouli","year":"2004","unstructured":"Papouli E, Cejka P, Jiricny J. Dependence of the cytotoxicity of DNA-damaging agents on the mismatch repair status of human cells. Cancer Res. 2004;64(10):3391\u20134.","journal-title":"Cancer Res"},{"issue":"2","key":"5218_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/sj.bjc.6605180","volume":"101","author":"X Ding","year":"2009","unstructured":"Ding X, Mohd AB, Huang Z, Baba T, Bernardini MQ, Lyerly HK, Berchuck A, Murphy SK, Buermeyer AB, Devi GR. MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition. Br J Cancer. 2009;101(2):269\u201377.","journal-title":"Br J Cancer"},{"issue":"13","key":"5218_CR26","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1242\/dev.032227","volume":"136","author":"A Ruzov","year":"2009","unstructured":"Ruzov A, Shorning B, Mortusewicz O, Dunican DS, Leonhardt H. Meehan RR.MBD4 and MLH1 are required for apoptotic induction in xDNMT1-depleted embryos. Development. 2009;136(13):2277\u201386.","journal-title":"Development"},{"issue":"7\u20138","key":"5218_CR27","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/sj.bjc.6690176","volume":"79","author":"A Nehme","year":"1999","unstructured":"Nehme A, Baskaran R, Nebel S, Fink D, Howell SB, Wang JY, Christen RD. Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells. Br J Cancer. 1999;79(7\u20138):1104\u201310.","journal-title":"Br J Cancer"},{"issue":"44","key":"5218_CR28","doi-asserted-by":"publisher","first-page":"32021","DOI":"10.1074\/jbc.M701451200","volume":"282","author":"WJ Kim","year":"2007","unstructured":"Kim WJ, Rajasekaran B, Brown KD. MLH1- and ATM-dependent MAPK signaling is activated through c-Abl in response to the alkylator N-methyl-N\u2019-nitro-N\u2019- nitrosoguanidine. J Biol Chem. 2007;282(44):32021\u201331.","journal-title":"J Biol Chem"},{"issue":"31","key":"5218_CR29","doi-asserted-by":"publisher","first-page":"21382","DOI":"10.1074\/jbc.M709953200","volume":"283","author":"MW Wagner","year":"2008","unstructured":"Wagner MW, Li LS, Morales JC, Galindo CL, Garner HR, Bornmann WG, Boothman DA. Role of c-Abl kinase in DNA mismatch repair-dependent G2 cell cycle checkpoint arrest responses. J Biol Chem. 2008;283(31):21382\u201393.","journal-title":"J Biol Chem"},{"issue":"1","key":"5218_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrm1280","volume":"5","author":"O Hantschel","year":"2004","unstructured":"Hantschel O, Superti-Furga G. Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat Rev Mol Cell Biol. 2004;5(1):33\u201344.","journal-title":"Nat Rev Mol Cell Biol."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5218-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-5218-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5218-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T19:08:49Z","timestamp":1577560129000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-5218-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5218"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-5218-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"21 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures were approved by the Laboratory Animal Ethics Committee of Qilu Hospital, Shandong University. The principles outlined in the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines and Basel declaration (including the 3\u2009R concept) were considered when planning experiments.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1294"}}